Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026)

Fortrea Holdings (FTRE) reported Total Liabilities of $2.2 billion for Q1 2026, down 4.63% on a YoY basis from $2.3 billion in Q1 2025, and little changed quarter-over-quarter from $2.2 billion in Q4 2025.

Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Total Liabilities for 5 years, with the latest figure at $2.2 billion in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities fell 4.63% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (down 4.63% YoY), and the FY2025 full-year result was $2.2 billion, down 2.91% from the prior year.
  • Total Liabilities for Q1 2026 stood at $2.2 billion, roughly flat from $2.2 billion in the prior quarter.
  • The five-year high for Total Liabilities was $2.6 billion in Q1 2024, with the low at -$3.4 billion in Q1 2023.
  • Historically, Total Liabilities has averaged $1.5 billion across 5 years, with a median of $2.2 billion in 2025.
  • Annual changes were most pronounced in 2023 — Total Liabilities surged 178.98% — and 2024, when it retreated 19.22%.
  • Fortrea Holdings' Total Liabilities stood at $945.3 million in 2022, then jumped by 177.0% to $2.6 billion in 2023, then fell by 15.34% to $2.2 billion in 2024, then fell by 2.91% to $2.2 billion in 2025, then advanced by 0.25% to $2.2 billion in 2026.
  • The last three Total Liabilities figures came in at $2.2 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.74 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 731.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 10.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 19.51 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 943,068.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.96 Bn 91.96 Bn - 137.56 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 2.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.16 Bn
Dec 31, 2025 2.15 Bn
Sep 30, 2025 2.16 Bn
Jun 30, 2025 2.25 Bn
Mar 31, 2025 2.26 Bn
Dec 31, 2024 2.22 Bn
Sep 30, 2024 2.15 Bn
Jun 30, 2024 2.10 Bn
Mar 31, 2024 2.65 Bn
Dec 31, 2023 2.62 Bn
Sep 30, 2023 2.62 Bn
Jun 30, 2023 2.61 Bn
Mar 31, 2023 -3.40 Bn
Dec 31, 2022 945.30 Mn
Jun 30, 2022 -3.30 Bn